Market closedNon-fractional

Axogen/AXGN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Axogen

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Ticker

AXGN

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Alachua, United States

Employees

427

Axogen Metrics

BasicAdvanced
$361M
Market cap
-
P/E ratio
-$0.49
EPS
1.02
Beta
-
Dividend rate
$361M
1.02
3.43
1.825
75.602
77.367
-3.63%
-6.21%
-22.32%
2.172
3.85
4.06
-15.972
13.51%
-16.37%
11.20%
-3.69%

What the Analysts think about Axogen

Analyst Ratings

Majority rating from 6 analysts.
Buy

Axogen Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-15.98% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$41M
-3.73%
Net income
-$6.6M
73.68%
Profit margin
-15.98%
80.56%

Axogen Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 11.76%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
$0.01
-$0.06
-$0.06
-
Expected
-$0.13
-$0.06
-$0.10
-$0.07
-$0.04
Surprise
-76.92%
-116.00%
-37.82%
-11.76%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Axogen stock?

Axogen (AXGN) has a market cap of $361M as of July 14, 2024.

What is the P/E ratio for Axogen stock?

The price to earnings (P/E) ratio for Axogen (AXGN) stock is 0 as of July 14, 2024.

Does Axogen stock pay dividends?

No, Axogen (AXGN) stock does not pay dividends to its shareholders as of July 14, 2024.

When is the next Axogen dividend payment date?

Axogen (AXGN) stock does not pay dividends to its shareholders.

What is the beta indicator for Axogen?

Axogen (AXGN) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Axogen stock

Buy or sell Axogen stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing